Related Experiment Video
Updated: Jan 24, 2026

Small Bowel Transplantation In Mice
Published on: August 20, 2007
Bowel preparation for small bowel capsule endoscopy - The later, the better!
S Xavier1, B Rosa1, S Monteiro1
1Hospital Senhora da Oliveira, Guimarães - Gastroenterology Department, Portugal; School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Guimarães/Braga, Portugal.
Administering Moviprep® after capsule arrival in the small bowel significantly improves visualization quality and diagnostic yield in capsule endoscopy. This enhanced preparation aids in detecting conditions like angioectasia.
Area of Science:
- Gastroenterology
- Medical Imaging
- Endoscopic Procedures
Background:
- Residue in the small bowel capsule endoscopy (SBCE) can significantly impair diagnostic accuracy.
- Optimizing bowel preparation is crucial for effective SBCE.
Purpose of the Study:
- To compare the visualization quality and diagnostic yield of SBCE across three distinct preparation protocols.
- To determine the optimal timing for Moviprep® administration for SBCE.
Main Methods:
- A prospective, randomized, blind pilot study involving 101 patients.
- Three protocols were evaluated: clear liquids only, Moviprep® the day before, and Moviprep® administered after capsule arrival in the small bowel.
- Small bowel preparation quality was assessed by two physicians based on adequate mucosal observation percentage.
Main Results:
- Protocol C, involving Moviprep® administration after capsule arrival, resulted in significantly higher excellent/good preparation rates for both readers (78.8% vs. 37.8-45.2%, p<0.003).
- Protocol C also demonstrated a higher detection rate of angioectasia (27.3% vs. 5.4-9.7%, p=0.022).
Conclusions:
- Administering Moviprep® after the capsule reaches the small bowel leads to superior small bowel preparation.
- This optimized protocol enhances the detection of angioectasia during SBCE.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Endoscopic Procedures III: Video Capsule Endoscopy

